Squamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth ...

Tumor hypoxia on 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) may serve as a reliable clinical biomarker of distant metastasis risk for patients with head and neck squamous cell ...

Lymphedema after head and neck cancer is considerably more common than previously assumed and can persist long after cancer ...

New research found patients with certain head and neck cancers lived longer and experienced fewer side effects when treated ...

Using 3D modeling to plan and guide cancer surgeries increases surgical precision, resulting in complete tumor removal for 92 ...

This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...

Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers. The new drug, still in preclinical studies, attacks cancer cells ...

She considers herself lucky. She happened to find a doctor who immediately did a biopsy and sent her sample to a lab that likely didn’t have much else to investigate during the pandemic. Whoever her ...